PH15963A - 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives - Google Patents

5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives

Info

Publication number
PH15963A
PH15963A PH23837A PH23837A PH15963A PH 15963 A PH15963 A PH 15963A PH 23837 A PH23837 A PH 23837A PH 23837 A PH23837 A PH 23837A PH 15963 A PH15963 A PH 15963A
Authority
PH
Philippines
Prior art keywords
benzodioxan
ylmethyl
dihydro
hydroxyethyl
amino
Prior art date
Application number
PH23837A
Other languages
English (en)
Inventor
Martin J Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of PH15963A publication Critical patent/PH15963A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
PH23837A 1979-05-04 1980-03-28 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives PH15963A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,243 US4206125A (en) 1979-05-04 1979-05-04 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives

Publications (1)

Publication Number Publication Date
PH15963A true PH15963A (en) 1983-05-04

Family

ID=21887496

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23837A PH15963A (en) 1979-05-04 1980-03-28 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives

Country Status (21)

Country Link
US (1) US4206125A (de)
JP (1) JPS55147274A (de)
AT (1) AT369365B (de)
AU (1) AU531739B2 (de)
BE (1) BE883087A (de)
CA (1) CA1148963A (de)
CH (1) CH645372A5 (de)
DE (1) DE3014738A1 (de)
DK (1) DK154503C (de)
ES (1) ES490814A0 (de)
FR (1) FR2455598A1 (de)
GB (1) GB2051780B (de)
IE (1) IE49564B1 (de)
IL (1) IL59681A (de)
IT (1) IT1127441B (de)
NL (1) NL8002208A (de)
NO (1) NO153572C (de)
NZ (1) NZ193236A (de)
PH (1) PH15963A (de)
SE (1) SE434745B (de)
ZA (1) ZA801603B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003022A1 (en) * 1986-10-31 1988-05-05 Pfizer Inc. Relatively low molecular weight polypeptides as renin inhibitors
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
AU2003298094A1 (en) * 2002-10-22 2004-05-13 Glaxo Group Limited Medicinal arylethanolamine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054104A (de) * 1962-07-20
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative

Also Published As

Publication number Publication date
AU5707780A (en) 1980-11-06
DK193580A (da) 1980-11-05
FR2455598A1 (fr) 1980-11-28
NO801296L (no) 1980-11-05
IT8048373A0 (it) 1980-04-09
DK154503C (da) 1989-04-10
AU531739B2 (en) 1983-09-01
FR2455598B1 (de) 1983-05-27
IE49564B1 (en) 1985-10-30
DE3014738C2 (de) 1989-08-03
US4206125A (en) 1980-06-03
DE3014738A1 (de) 1980-11-13
IT1127441B (it) 1986-05-21
NO153572B (no) 1986-01-06
NL8002208A (nl) 1980-11-06
ES8104997A1 (es) 1981-05-16
CA1148963A (en) 1983-06-28
ES490814A0 (es) 1981-05-16
NZ193236A (en) 1982-09-14
GB2051780A (en) 1981-01-21
IE800572L (en) 1980-11-04
GB2051780B (en) 1982-12-22
ATA232780A (de) 1982-05-15
JPS642115B2 (de) 1989-01-13
SE8003243L (sv) 1980-11-05
IL59681A (en) 1984-04-30
DK154503B (da) 1988-11-21
CH645372A5 (de) 1984-09-28
AT369365B (de) 1982-12-27
NO153572C (no) 1986-04-16
JPS55147274A (en) 1980-11-17
BE883087A (fr) 1980-09-01
SE434745B (sv) 1984-08-13
ZA801603B (en) 1981-03-25
IL59681A0 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
AU539519B2 (en) 7(2-(2-aminothiazol-4-yl)-2(2-carboxyprop-2-oxyimino) acteamido)-3-(1-pyridiniumethyl)ceph 3-em-4-carboxylate
AU536316B2 (en) 2,3-dihydro-1h-indole derivatives
AU535320B2 (en) 2-(2-(1,4-benzodioxanyl))-2-imidazoling derivatives
GB2045757B (en) 1,2,3-thiadiazole-5-carboxylic acid derivatives
IL61575A (en) 4(5),13(14)-diunsaturated 16-hydroxy-prostanoic acid derivatives
DE3473443D1 (en) New amino derivatives of 2- (n-(2,2,5,5-tetramethyl-3-pyrrolin-or pyrrolidine-3-carbonyl))
PH15963A (en) 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)-1-hydroxyethyl)-2-hydroxybenzoic acid derivatives
RO81212A (ro) Procedeu pentru prepararea unor 2',6'-dialchil-n-(alcoximetil)2-cloracetanilide
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
GB2020652B (en) 7(2-(w-1,3-dithiolan-2-imino)substituted)-acetylamino) cephalosporanic acid derivatives
AU565660B2 (en) N-(2-(1,2-dichlorovinyloxy)-phenylsulphonyl)-(thio)ureas
AU533137B2 (en) 1,2,3-thiadiazol-5-yl urea derivatives
ES544201A0 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
FI800106A (fi) Foerfarande foer separering av d,1 2-(6-metoxi-2-naftyl)propionsyra
AU534572B2 (en) 6b-(2-(2:-methylphenorgcarbonyl)-2-thien-3:-ylacetamido)
AU5865980A (en) Salts of herbicidal 1,2,4-thiadiazolyl-5-urea derivatives
DE3067029D1 (en) Process for the preparation of 2,2'-imino-bis benzothiazole compounds
AU534495B2 (en) 1,2,4-benzotriazin-3-yl amino compounds
AU1974283A (en) 2,3-dihydro-2,2-dimethyl-benzofuran derivatives
DE3362389D1 (en) Substituted n-(2,4-dinitro-6-(trifluoromethyl)phenyl)-naphthalenamine derivatives
AU568448B2 (en) 2-(2-fluoro-4-halo-5-substituted phenyl) urea derivatives
AU529943B2 (en) 5-(2-((3-(1,3-benzodioxol-5-yl)-1-methylpropyl)amino)-1- hydroxyethyl)-2-methoxybenzamide
AU525112B2 (en) 2-(2'2'2'-tribromomethyl)-4-chlorocyclobutan-1-ones
FI782961A (fi) Foerfarande foer framstaellning av 2-(2',2',2'-tribrometyl)-4-klorcyklobutan-1-oner
GB2044753B (en) Derivatives of 1,4 - dihydropyridine - 3 - carbothiol acids

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14